![](/images/general/no_picture/200_user.png)
Kurt Fernstrom
Examiner (ID: 5518, Phone: (571)272-4422 , Office: P/3711 )
Most Active Art Unit | 3711 |
Art Unit(s) | 3714, 3712, 3715, 3711 |
Total Applications | 2669 |
Issued Applications | 1756 |
Pending Applications | 157 |
Abandoned Applications | 755 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10481956
[patent_doc_number] => 20150366973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'PEPTIDE SLOW-RELEASE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/598852
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12793
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598852
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/598852 | PEPTIDE SLOW-RELEASE FORMULATIONS | Jan 15, 2015 | Abandoned |
Array
(
[id] => 16041075
[patent_doc_number] => 10682388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Targeting of PELP1 in cancer therapy
[patent_app_type] => utility
[patent_app_number] => 15/110426
[patent_app_country] => US
[patent_app_date] => 2015-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 28753
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110426
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/110426 | Targeting of PELP1 in cancer therapy | Jan 13, 2015 | Issued |
Array
(
[id] => 11768131
[patent_doc_number] => 09376710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'Methods of localizing nucleic acids to arrays'
[patent_app_type] => utility
[patent_app_number] => 14/592766
[patent_app_country] => US
[patent_app_date] => 2015-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 21580
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14592766
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/592766 | Methods of localizing nucleic acids to arrays | Jan 7, 2015 | Issued |
Array
(
[id] => 11127842
[patent_doc_number] => 20160324817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'CONTROLLED RELEASE FATTY ACID COMPOSITIONS FOR USE IN BODY RECONSTRUCTION AND BODY-SHAPING'
[patent_app_type] => utility
[patent_app_number] => 15/108782
[patent_app_country] => US
[patent_app_date] => 2014-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8240
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/108782 | Controlled release fatty acid compositions for use in body reconstruction and body-shaping | Dec 29, 2014 | Issued |
Array
(
[id] => 11290457
[patent_doc_number] => 20160340389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/108004
[patent_app_country] => US
[patent_app_date] => 2014-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28147
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108004
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/108004 | Pharmaceutically relevant aromatic-cationic peptides | Dec 22, 2014 | Issued |
Array
(
[id] => 11114893
[patent_doc_number] => 20160311867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'PESTICIDAL FUSION PROTEIN IMPROVEMENTS'
[patent_app_type] => utility
[patent_app_number] => 15/103810
[patent_app_country] => US
[patent_app_date] => 2014-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16994
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103810
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/103810 | PESTICIDAL FUSION PROTEIN IMPROVEMENTS | Dec 10, 2014 | Abandoned |
Array
(
[id] => 11915401
[patent_doc_number] => 09783578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Immunosuppression modulating compounds'
[patent_app_type] => utility
[patent_app_number] => 14/563568
[patent_app_country] => US
[patent_app_date] => 2014-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 33117
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14563568
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/563568 | Immunosuppression modulating compounds | Dec 7, 2014 | Issued |
Array
(
[id] => 10272694
[patent_doc_number] => 20150157691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'Galectin-3 to Treat Ovarian Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/561981
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9562
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14561981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/561981 | Galectin-3 to Treat Ovarian Cancer | Dec 4, 2014 | Abandoned |
Array
(
[id] => 11099620
[patent_doc_number] => 20160296589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING VITILIGO'
[patent_app_type] => utility
[patent_app_number] => 15/100926
[patent_app_country] => US
[patent_app_date] => 2014-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24856
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15100926
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/100926 | Compositions and methods for treating vitiligo | Dec 1, 2014 | Issued |
Array
(
[id] => 9932125
[patent_doc_number] => 20150080317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'TEMPLATE-FIXED PEPTIDOMIMETICS'
[patent_app_type] => utility
[patent_app_number] => 14/555796
[patent_app_country] => US
[patent_app_date] => 2014-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6803
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14555796
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/555796 | Template-fixed peptidomimetics | Nov 27, 2014 | Issued |
Array
(
[id] => 9932357
[patent_doc_number] => 20150080550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'Process for the Production of Bivalirudin'
[patent_app_type] => utility
[patent_app_number] => 14/552807
[patent_app_country] => US
[patent_app_date] => 2014-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18633
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14552807
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/552807 | Process for the Production of Bivalirudin | Nov 24, 2014 | Abandoned |
Array
(
[id] => 10613805
[patent_doc_number] => 09333233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Methods and compositions for the delayed treatment of stroke'
[patent_app_type] => utility
[patent_app_number] => 14/549096
[patent_app_country] => US
[patent_app_date] => 2014-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 24844
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14549096
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/549096 | Methods and compositions for the delayed treatment of stroke | Nov 19, 2014 | Issued |
Array
(
[id] => 11768825
[patent_doc_number] => 09377471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'Methods and compositions for the treatment of β-thalassemia'
[patent_app_type] => utility
[patent_app_number] => 14/547208
[patent_app_country] => US
[patent_app_date] => 2014-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12551
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14547208
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/547208 | Methods and compositions for the treatment of β-thalassemia | Nov 18, 2014 | Issued |
Array
(
[id] => 10045249
[patent_doc_number] => 09085637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Selective PYY compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/540474
[patent_app_country] => US
[patent_app_date] => 2014-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27150
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14540474
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/540474 | Selective PYY compounds and uses thereof | Nov 12, 2014 | Issued |
Array
(
[id] => 10248370
[patent_doc_number] => 20150133366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CLOSTRIDIUM INFECTION AND PREVENTING RECURRENCE OF INFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/539214
[patent_app_country] => US
[patent_app_date] => 2014-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15888
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14539214
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/539214 | Compositions and methods for treating clostridium infection and preventing recurrence of infection | Nov 11, 2014 | Issued |
Array
(
[id] => 11099630
[patent_doc_number] => 20160296600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'Relaxin Prodrugs'
[patent_app_type] => utility
[patent_app_number] => 15/035636
[patent_app_country] => US
[patent_app_date] => 2014-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 34348
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035636
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035636 | Relaxin Prodrugs | Nov 9, 2014 | Abandoned |
Array
(
[id] => 11067672
[patent_doc_number] => 20160264636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'PEPTIDE INHIBITORS OF TEAD/YAP-TAZ INTERACTION'
[patent_app_type] => utility
[patent_app_number] => 15/031754
[patent_app_country] => US
[patent_app_date] => 2014-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9675
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031754
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/031754 | Peptide inhibitors of TEAD/YAP-TAZ interaction | Nov 3, 2014 | Issued |
Array
(
[id] => 10319865
[patent_doc_number] => 20150204868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'PEPTIDES, DEVICES, AND METHODS FOR THE DETECTION OF ANAPLASMA ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 14/511916
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 50920
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511916
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/511916 | Peptides, devices, and methods for the detection of Anaplasma antibodies | Oct 9, 2014 | Issued |
Array
(
[id] => 10754880
[patent_doc_number] => 20160101031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'Methods of Regulating Skin Health and Appearance with a Combination of Flavonoid and Vitamin B3'
[patent_app_type] => utility
[patent_app_number] => 14/511445
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10998
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511445
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/511445 | Methods of regulating skin health and appearance with a combination of flavonoid and vitamin B3 | Oct 9, 2014 | Issued |
Array
(
[id] => 9839552
[patent_doc_number] => 20150031634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'ANGIOTENSIN PEPTIDES IN TREATING MARFAN SYNDROME AND RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/506489
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22020
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14506489
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/506489 | Angiotensin peptides in treating marfan syndrome and related disorders | Oct 2, 2014 | Issued |